<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR47">
 <label>47.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bikdeli</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Madhavan</surname>
    <given-names>MV</given-names>
   </name>
   <name>
    <surname>Jimenez</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Chuich</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Dreyfus</surname>
    <given-names>I</given-names>
   </name>
   <name>
    <surname>Driggin</surname>
    <given-names>E</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-Up: JACC state-of-the-art review</article-title>
  <source>J Am Coll Cardiol.</source>
  <year>2020</year>
  <volume>75</volume>
  <issue>23</issue>
  <fpage>2950</fpage>
  <lpage>73</lpage>
  <pub-id pub-id-type="doi">10.1016/j.jacc.2020.04.031</pub-id>
  <pub-id pub-id-type="pmid">32311448</pub-id>
 </element-citation>
</ref>
